Erratum: The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics (European Respiratory Journal (2001) vol. 18 (254-261))

Annotation

Peer reviewed

M. Solèr, J. Matz, R. Townley, R. Buhl, J. O'Brien, H. Fox, J. Thirlwell, N. Gupta and G. Della Cioppa

European Respiratory Journal, Vol.18(4), pp.739-740

18

2001

Abstract

Pulmonary and Respiratory Medicine

4 Record Views

Title: Erratum
Creators: M. Solèr (Author)
J. Matz (Author)
R. Townley (Author) - Department of Medicine
R. Buhl (Author)
J. O'Brien (Author)
H. Fox (Author)
J. Thirlwell (Author)
N. Gupta (Author)
G. Della Cioppa (Author)
Additional links: Clark, Terry D.; Potter, Joshua D.; Larson, Jennifer M.; Mordeson, John N.; Wierman, Mark J.
Publication Details: European Respiratory Journal, Vol.18(4), pp.739-740
Series: 18
Number of pages: 2
Identifiers: 991005930965602656
Academic Unit: General Medicine
Language: English
Resource Type: Annotation